Trial Profile
Response Rate and Response Duration After Discontinuation of Treatment With Thrombopoietin Receptor Agonists in Patients Affected by Primary Immune Thrombocytopenia (pITP): Retrospective Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 22 Oct 2018 Planned End Date changed from 1 Mar 2018 to 1 Dec 2018.
- 22 Oct 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Dec 2018.
- 20 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Mar 2018.